Key result
Systematic BP measurement bias increases untreated high BP prevalence by ~12 percentage points.
Why the study?
The proportion of US adults whose high blood pressure status would change if systolic and diastolic blood pressure were measured with systematic bias or random error instead of a standardized protocol required examination.
Does systematic bias or random error in office blood pressure measurement alter the estimated prevalence and classification of high blood pressure compared with a standardized measurement protocol in US adults?
Cross-Sectional (n=5,176)
Yes
Does systematic bias or random error in office blood pressure measurement alter the estimated prevalence and classification of high blood pressure compared with a standardized measurement protocol in US adults?
Modest systematic bias or random error in routine blood pressure measurement can misclassify high blood pressure status in tens of millions of US adults, underscoring the critical need for standardized measurement protocols in clinical practice.
Answers are grounded in this paper and cite their sources.
BP measurement bias may inflate high BP prevalence estimates; leaves open accurate burden assessment without standardized protocols.
The authors examined the proportion of US adults that would have their high blood pressure (BP) status changed if systolic BP (SBP) and diastolic BP (DBP) were measured with systematic bias and/or random error versus following a standardized protocol. Data from the 2017-2018 National Health and Nutrition Examination Survey (NHANES; n = 5176) were analyzed. BP was measured up to three times using a mercury sphygmomanometer by a trained physician following a standardized protocol and averaged. High BP was defined as SBP ≥130 mm Hg or DBP ≥80 mm Hg. Among US adults not taking antihypertensive medication, 32.0% (95%CI: 29.6%,34.4%) had high BP. If SBP and DBP were measured with systematic bias, 5 mm Hg for SBP and 3.5 mm Hg for DBP higher and lower than in NHANES, the proportion with high BP was estimated to be 44.4% (95%CI: 42.6%,46.2%) and 21.9% (95%CI 19.5%,24.4%). Among US adults taking antihypertensive medication, 60.6% (95%CI: 57.2%,63.9%) had high BP. If SBP and DBP were measured 5 and 3.5 mm Hg higher and lower than in NHANES, the proportion with high BP was estimated to be 71.8% (95%CI: 68.3%,75.0%) and 48.4% (95%CI: 44.6%,52.2%), respectively. If BP was measured with random error, with standard deviations of 15 mm Hg for SBP and 7 mm Hg for DBP, 21.4% (95%CI: 19.8%,23.0%) of US adults not taking antihypertensive medication and 20.5% (95%CI: 17.7%,23.3%) taking antihypertensive medication had their high BP status re-categorized. In conclusions, measuring BP with systematic or random errors may result in the misclassification of high BP for a substantial proportion of US adults.
No takes yet. Share an insight, caveat, or question.
Sakhuja et al. (2022) conducted a cross-sectional in High blood pressure (SBP >=130 mm Hg or DBP >=80 mm Hg) (n=5,176). Simulated systematic bias (+5/3.5 mm Hg SBP/DBP) or random error (SD 15/7 mm Hg SBP/DBP) in blood pressure measurement vs. Standardized blood pressure measurement protocol using a mercury sphygmomanometer (NHANES protocol) was evaluated on Estimated prevalence of high blood pressure (SBP >=130 mm Hg or DBP >=80 mm Hg) among US adults not taking antihypertensive medication with +5/3.5 mm Hg systematic bias vs standardized protocol (Difference +12.4%, 95% CI 10.6%-14.5%). Simulated +5/3.5 mm Hg systematic BP measurement bias increased estimated high BP prevalence from 32.0% to 44.4% in untreated US adults and from 60.6% to 71.8% in treated adults.
Synapse has enriched 10 related papers. Consider them for comparative context: